Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Smyth

Showing results (1-10 of 494) with videos related to

Pageof 50
Sort By:
International Immunology|March 13, 2008
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcomaMark J Smyth
Immunology and Cell Biology|February 9, 2017
Multiple approaches to immunotherapy - the new pillar of cancer treatmentMark J Smyth
Nature Immunology|June 23, 2005
Type I interferon and cancer immunoeditingMark J Smyth
Blood|April 10, 2008
Clarification of data used in three studies on MCA-induction of sarcoma in miceMark J Smyth
The New England Journal of Medicine|May 26, 2006
Imatinib mesylate--uncovering a fast track to adaptive immunityMark J Smyth
Current Opinion in Immunology|February 15, 2021
Innate myeloid cells in the tumor microenvironmentVikas Duhan, Mark J Smyth
British Journal of Cancer|June 15, 2018
TGFβ shuts the door on T cellsTobias Bald, Mark J Smyth
Cancer Cell|August 17, 2010
Her 2 in 1Mark J Smyth, John Stagg
Current Topics in Microbiology and Immunology|May 31, 2015
NK Cells and Cancer ImmunoeditingCamille Guillerey, Mark J Smyth
Nature Biotechnology|February 9, 2007
Calreticulin exposure increases cancer immunogenicityChris Clarke, Mark J Smyth
Pageof 50

Showing results (1-10 of 494) with videos related to

Sort By:
Pageof 50
International Immunology|March 13, 2008
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcomaMark J Smyth
Immunology and Cell Biology|February 9, 2017
Multiple approaches to immunotherapy - the new pillar of cancer treatmentMark J Smyth
Nature Immunology|June 23, 2005
Type I interferon and cancer immunoeditingMark J Smyth
Blood|April 10, 2008
Clarification of data used in three studies on MCA-induction of sarcoma in miceMark J Smyth
The New England Journal of Medicine|May 26, 2006
Imatinib mesylate--uncovering a fast track to adaptive immunityMark J Smyth
Current Opinion in Immunology|February 15, 2021
Innate myeloid cells in the tumor microenvironmentVikas Duhan, Mark J Smyth
British Journal of Cancer|June 15, 2018
TGFβ shuts the door on T cellsTobias Bald, Mark J Smyth
Cancer Cell|August 17, 2010
Her 2 in 1Mark J Smyth, John Stagg
Current Topics in Microbiology and Immunology|May 31, 2015
NK Cells and Cancer ImmunoeditingCamille Guillerey, Mark J Smyth
Nature Biotechnology|February 9, 2007
Calreticulin exposure increases cancer immunogenicityChris Clarke, Mark J Smyth
Pageof 50